| COVID-19 |
1 |
1 |
| Child |
0 |
0.95 |
| Severe Acute Respiratory Syndrome |
0 |
0.9 |
| Otolaryngology |
0 |
0.6 |
| Acute Respiratory Distress Syndrome |
0 |
0.88 |
| Airway |
0 |
0.94 |
| Antiviral Agents |
0 |
0.08 |
| Respiratory Tract |
0 |
0.08 |
| T-Lymphocyte |
0 |
0.08 |
| Biologic Therapy |
0 |
0.04 |
| Biomedical Technology |
0 |
0.04 |
| Epidemiology |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Immunology |
0 |
0.04 |
| Memory |
0 |
0.04 |
| Nose |
0 |
0.04 |
| Pennsylvania |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Respiratory Tract Infections |
0 |
0.04 |
| Viral Infection |
0 |
0.04 |